Translate
Text Highlighter

Bookmark

PDF

Share

Report a problem
AMICUS AI
Citation Codes
Neutral Citations
1998 INSC 108
Equivalent Citations
citation codes
Case Number
Disposition
Advocates
Judges
Acts
  • Section 28 of the Act
  • Section 27(b)(ii) of the Act
  • Section 18, Chapter of the Act
  • Section 18-A of the Act
  • Section 27(b)(ii) and Section 28 of the Drugs and Cosmetics Act, 1940
  • clause (c) of Section 18 of the Act
  • Section 24 of the Act
Are you a practicing lawyer?
Enhance your digital presence and reach by creating a Casemine profile.
Upload pleading to use the new AI search
Cites
Cited by
Citation Codes
Neutral Citations
1998 INSC 108
Equivalent Citations
citation codes
Case Number
Disposition
Advocates
Judges
Acts
  • Section 28 of the Act
  • Section 27(b)(ii) of the Act
  • Section 18, Chapter of the Act
  • Section 18-A of the Act
  • Section 27(b)(ii) and Section 28 of the Drugs and Cosmetics Act, 1940
  • clause (c) of Section 18 of the Act
  • Section 24 of the Act
Smart Summary

Factual and Procedural Background

On 7 August 1986*, a Drugs Inspector, accompanied by a Deputy Drugs Controller and an Assistant Drugs Controller, searched the premises of “Kalicharan Polyclinic,” a nursing home run by the respondent in Jaleswar, Orissa. Two almirahs in the front room contained 22 varieties of medicinal drugs that were being stocked for sale. The respondent neither possessed the requisite licence under Clause (c) of Section 18 of the Drugs and Cosmetics Act, 1940, nor could he produce purchase invoices or disclose the source of the drugs.

The respondent was prosecuted before a Judicial Magistrate First Class for (i) stocking drugs for sale without a licence (Section 27(b)(ii)) and (ii) failing to disclose the source of the drugs (Section 28, read with Section 18-A). The Magistrate convicted him on both counts, sentencing him to:

  • Simple imprisonment for one year and a fine of ₹5,000 for the Section 27(b)(ii) offence; and
  • Simple imprisonment for one month for the Section 28 offence.

The Sessions Court dismissed his appeal, affirming the conviction and sentence. In revision, the Orissa High Court acquitted the respondent under Section 28 and reduced the sentence under Section 27(b)(ii) to the period already undergone and a fine of ₹3,000.

The State of Orissa sought special leave, challenging both the acquittal under Section 28 and the reduced sentence under Section 27(b)(ii). The Supreme Court granted leave and heard the appeal.

*The first paragraph of the opinion refers to 7-8-1996, while later portions mention 7-8-1986.

Legal Issues Presented

  1. Whether the High Court erred in acquitting the respondent of the offence under Section 28 by misinterpreting the scope of Section 18-A of the Drugs and Cosmetics Act, 1940.
  2. Whether the High Court possessed jurisdiction and adequate grounds to reduce the sentence for the offence under Section 27(b)(ii) below the statutory minimum.

Arguments of the Parties

Appellant (State of Orissa)

  • The High Court misread Section 18-A by excluding persons other than manufacturers and their agents, thereby wrongly holding that the respondent could not be prosecuted under Section 28.
  • The reduction of sentence under Section 27(b)(ii) to the period already undergone and a fine of ₹3,000 was without jurisdiction and contrary to the mandatory minimum prescribed by the statute.

Table of Precedents Cited

Precedent Rule or Principle Cited For Application by the Court
Ram Shankar Misra v. State of U.P., (1980) 1 SCC 255; AIR 1979 SC 727 Sentence under Section 27 cannot be reduced to a fine only; imprisonment is mandatory. Reaffirmed that some term of imprisonment must accompany any fine under Section 27(b)(ii).
Rajasthan Pharmaceutical Laboratory v. State of Karnataka, (1981) 1 SCC 645; AIR 1981 SC 809 Imprisonment is compulsory under Section 27(b)(ii), subject to the proviso allowing reduction for adequate and special reasons. Relied on to hold that the court retains discretion to reduce imprisonment below one year if adequate and special reasons are recorded.

Court's Reasoning and Analysis

On Section 28 / Section 18-A: The Court observed that Section 18-A explicitly applies to “every person, not being the manufacturer or his agent,” obligating such persons to disclose the source of the drug upon demand. The High Court’s interpretation—limiting the section to manufacturers or their agents—ignored the crucial word “not” and inverted the statutory scheme. Consequently, acquittal under Section 28 was founded on a “basically faulty premise” and had to be overturned.

Sentencing under Section 28: Although the conviction was restored, the Court noted that (i) non-disclosure might stem from genuine inability to remember, and (ii) no evidence suggested the seized drugs were spurious, misbranded, or expired. Given that Section 28 allows imprisonment or fine, a monetary penalty of ₹1,000 was deemed sufficient, with a default sentence of one month’s simple imprisonment.

On Reduction of Sentence under Section 27(b)(ii): The statute prescribes a minimum of one year’s imprisonment and ₹5,000 fine, but the proviso empowers courts to impose lower sentences for “adequate and special reasons.” Supreme Court precedents confirm this discretion. The High Court recorded reasons for reduction, and the State’s special-leave petition did not dispute their adequacy. The Supreme Court therefore declined to enhance either the imprisonment or fine.

Holding and Implications

HOLDING: The appeal is ALLOWED IN PART. The Supreme Court:

  • Sets aside the High Court’s acquittal under Section 28 and restores the respondent’s conviction.
  • Imposes a fine of ₹1,000 for the Section 28 offence, with one month’s simple imprisonment in default of payment within two months.
  • Affirms the reduced sentence (imprisonment already undergone and ₹3,000 fine) for the Section 27(b)(ii) offence.

Implications: The decision clarifies that Section 18-A applies to all non-manufacturer holders of drugs, reinforcing disclosure obligations. It also confirms that, while imprisonment under Section 27(b)(ii) is generally mandatory, courts may reduce the term below one year if they record adequate and special reasons. No new precedent is set on sentencing parameters, but the ruling underscores the necessity of correctly reading statutory language.

To access the original judgment, please Sign In or Subscribe.

    State Of Orissa v. Janmejoy Dinda .

    K.T Thomas, J.— A Drugs Inspector conducted search of the premises of a nursing home run by the respondent under the name “Kalicharan Polyclinic” at Naya Bazar in Jaleswar (Orissa) on 7-8-1996. He was accompanied by one Deputy Drugs Controller and an Assistant Drugs Controller. In the search it was detected that medicinal drugs were stocked for sale in two almirahs kept in the front room of the nursing home. As the respondent had no licence to stock or exhibit for sale such drugs, the Drugs Inspector seized 22 items of drugs. The respondent was not able to produce the purchase invoice concerning those drugs and he failed to disclose the source from which he purchased them.

    2. On the aforesaid facts the respondent was prosecuted before a Court of Judicial Magistrate of First Class for offences under Section 27(b)(ii) and Section 28 of the Drugs and Cosmetics Act, 1940 (for short “the Act”). The Magistrate, on conclusion of the trial, convicted the respondent under both counts and sentenced him to undergo simple imprisonment for one year and a fine of Rs 5000 on the first count and to simple imprisonment for one month on the second count.

    3. Appeal filed by the respondent was dismissed by the Sessions Court which confirmed the conviction and sentence under both charges. But when he filed a revision before the High Court of Orissa, a learned Single Judge found that conviction under Section 28 of the Act was unsustainable and hence the respondent was acquitted of that offence. In the matter of sentence for the offence under Section 27(b)(ii) of the Act learned Single Judge reduced it to the period of imprisonment which had already been undergone and the fine was reduced to Rs 3000.

    4. State of Orissa has filed this special leave petition challenging the aforesaid alteration and modification made by the High Court. Leave is granted.

    5. The concurrent findings of facts arrived at by the trial court and the appellate court which are not liable to be reopened are: (1) the respondent stocked for sale the drugs seized from his nursing home on 7-8-1986 without any valid licence as required under clause (c) of Section 18 of the Act, and (2) the respondent did not disclose to the Drugs Inspector, even after he was required to do so, the name and address of the persons from whom he acquired those drugs.

    6. Learned counsel for the appellant contended that the High Court committed an error in holding that the offence under Section 28 of the Act has not been made out. That section reads thus:

    “28. Penalty for non-disclosure of the name of the manufacturer, etc.—Whoever contravenes the provisions of Section 18-A or Section 24 shall be punishable with imprisonment for a term which may extend to one year, or with fine which may extend to one thousand rupees, or with both.”

    7. Learned Single Judge of the High Court took the view that Section 18-A of the Act would have application “only if the person from whom the requisite information is sought for, is either the manufacturer or an agent for distribution” and since the respondent was neither of them he could not have contravened the section. The reasoning of the learned Single Judge in reaching the aforesaid conclusion, in his own words, is the following:

    “Section 18-A deals with disclosure of the name of the manufacturer, etc. It requires that every person, being the manufacturer of a drug or cosmetic or his agent for the distribution thereof, shall, if so required, disclose to the Inspector the name, address and other particulars of the person from whom he acquired the drug or cosmetic. In order to attract application of Section 18-A, a person, who is either the manufacturer of the drug or cosmetic or agent for distribution thereof is required to disclose to the Inspector the name and address and other particulars of the person from whom he acquired the articles. If a person does not fall within either of the two categories, Section 18-A will have no application.”

    8. In this context it is necessary, to see how Section 18-A of the Act is worded which is extracted below:

    “18-A. Disclosure of the name of the manufacturer, etc.—Every person, not being the manufacturer of a drug or cosmetic or his agent for the distribution thereof, shall, if so required, disclose to the Inspector the name, address and other particulars of the person from whom he acquired the drug or cosmetic.”

    (emphasis supplied)

    9. It is obvious that for application of the section, the person concerned shall not be a manufacturer of drug or his agent. In other words, the person to whom Section 18-A applies is anyone other than a manufacturer or his agent for distribution thereof. The raison d'être of it is that, if he is the manufacturer or his agent he cannot disclose the name of the person from whom he acquired the drug because he himself is its manufacturer. To expect the other way is to expect the impossible. Hence there is no question of requiring him to disclose the identity of the person from whom he acquired the drug. Exclusion of manufacturer and his agent from the purview of Section 18-A is, therefore, on understandable premise.

    10. It seems to us that learned Single Judge of the High Court would have missed the monosyllable “not” in Section 18-A of the Act when he considered the amplitude of the provision. The position of law when the word “not” is remaining in the provision, is just the other way around. The section, therefore, would apply to any person other than the manufacturer of a drug or cosmetic or his agent. Hence, there is much force in the contention of the State that acquittal of the respondent of the offence under Section 28 of the Act is based on a basically faulty premise. Such acquittal is, therefore, liable to be set aside and the conviction of the respondent under Section 28 has to be restored. We do so.

    11. However, while dealing with the sentence we are of the opinion that for failure to disclose the name of the person from whom he acquired the drugs, he need not be sent to jail as we feel that such failure could have happened perhaps because he was oblivious of the name and address of the person from whom he purchased the drugs. That apart, there is no case for the Drug Inspector, or for the prosecution itself, that any of the drugs seized from the nursing home was either a spurious drug or a misbranded one or even a time-expired medicine. It means that the drugs seized would have been otherwise genuine medicine.

    12. We also notice that the offence under Section 28 is punishable with either imprisonment or with fine which may extend to Rs 1000 or with both. In other words, sentence of imprisonment is not compulsory. In such circumstances, a sentence of fine of Rs 1000 would be sufficient to meet the ends of justice for Section 28 of the Act so far as the facts in this case are concerned.

    13. The remaining contention is that learned Single Judge has acted without jurisdiction when he reduced the sentence for the offence under Section 27(b)(ii) of the Act to imprisonment for the period which the respondent had already undergone and to a fine of Rs 3000. For considering the above contention it is necessary to extract the material portion of the said sub-clause:

    “27. Penalty for manufacture, sale, etc., of drugs in contravention of this Chapter.—Whoever, himself or by any other person on his behalf, manufactures for sale or for distribution, or sells, or stocks or exhibits or offers for sale or distributes,—

    (b) any drug—

    (ii) without a valid licence as required under clause (c) of Section 18,

    shall be punishable with imprisonment for a term which shall not be less than one year but which may extend to three years and with fine which shall not be less than five thousand rupees:

    Provided that the Court may, for any adequate and special reasons to be recorded in the judgment, impose a sentence of imprisonment for a term of less than one year and of fine of less than five thousand rupees;”

    14. This Court has held in Ram Shankar Misra v. State of U.P (1980) 1 SCC 255, AIR 1979 SC 727 that the sentence under Section 27 of the Act cannot be reduced to one of fine only. Again in Rajasthan Pharmaceutical Laboratory v. State of Karnataka (1981) 1 SCC 645, AIR 1981 SC 809 this Court pointed out that a sentence of imprisonment is compulsory under Section 27(b)(ii) of the Act. But in view of the proviso to the section (as quoted above) it cannot be said that the Court has no jurisdiction to reduce the sentence of imprisonment below the period of six months. If the conditions specified in the proviso are present, the Court has the power to reduce the sentence even further down. For that there must be adequate and special reasons and such reasons should be recorded in the judgment and there shall still be a term of imprisonment and fine in the reduced sentence.

    15. Learned Single Judge has given some reasons for reducing the sentence of imprisonment “to the period already undergone” and to a fine of Rs 3000. The appellant-State has not even mentioned in the special leave petition that the reasons shown by the learned Single Judge are neither adequate nor special. We are, therefore, not inclined to enhance the term of imprisonment or the quantum of fine further upward for the offence under Section 27(b)(ii) of the Act.

    16. In the result, we allow this appeal by setting aside the acquittal under Section 28 of the Act. We restore the conviction of the respondent for the said offence. We impose a fine of Rs 1000 on him for the said offence and direct that in default of payment of such fine within two months the respondent shall undergo simple imprisonment for one month. Appeal is thus allowed to that extent.

    Use AI to get other relevant cases.

    Comments

    State Of Orissa v. Janmejoy Dinda .
    (Feb 20, 1998)